Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Materials (Basel, Switzerland)|March 8, 2019
Surface Modification of Liposomes by a Lipopolymer Targeting Prostate Specific Membrane Antigen for Theranostic Delivery in Prostate CancerHooman Yari, Gregory Nkepang, Vibhudutta Awasthi
Current Pharmaceutical Design|July 23, 2020
Nanoparticles for Targeting of Prostate CancerHooman Yari, Hariprasad Gali, Vibhudutta Awasthi
Journal of Pharmaceutical Analysis|February 7, 2018
Stability study on an anti-cancer drug 4-(3,5-bis(2-chlorobenzylidene)-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid (CLEFMA) using a stability-indicating HPLC methodDhawal Raghuvanshi, Gregory Nkepang, Alamdar Hussain, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|May 11, 2018
Induction of gut proteasome activity in hemorrhagic shock and its recovery by treatment with diphenyldihaloketones CLEFMA and EF24Geeta Rao, Hailey Houson, Gregory Nkepang, et al.
The EMBO Journal|October 31, 2022
Subcellular location of source proteins improves prediction of neoantigens for immunotherapyAndrea Castro, Saghar Kaabinejadian, Hooman Yari, et al.
Frontiers in Immunology|February 14, 2022
Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR ImmunopeptidomeSaghar Kaabinejadian, Carolina Barra, Bruno Alvarez, et al.
Frontiers in Chemistry|October 4, 2018
Ubiquitin Receptor RPN13 Mediates the Inhibitory Interaction of Diphenyldihaloketones CLEFMA and EF24 With the 26S ProteasomeGeeta Rao, Gregory Nkepang, Jian Xu, et al.
Communications Biology|April 21, 2023
Machine learning reveals limited contribution of trans-only encoded variants to the HLA-DQ immunopeptidomeJonas Birkelund Nilsson, Saghar Kaabinejadian, Hooman Yari, et al.
Iscience|May 27, 2026
Presentation of identical tumor antigen peptides by canine and human MHC class ISaghar Kaabinejadian, Hooman Yari, Steven Cate, et al.
Science Advances|November 24, 2023
Accurate prediction of HLA class II antigen presentation across all loci using tailored data acquisition and refined machine learningJonas B Nilsson, Saghar Kaabinejadian, Hooman Yari, et al.
Pageof 2